NFKB1 and Duchenne muscular dystrophy: Our recent studies have shown that the inhibition of the NF-κB signaling pathway can improve both limb and diaphragm muscle contractile function in the dystrophin-deficient mdx genotypic mouse model of DMD[5,6].